Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588067 · ClinicalTrials.gov registry record
Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease
A clinical trial of Peripheral Arterial Disease, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 271
- Enrollment target
- 2
- Study locations
NCT01588067: Completed study of Peripheral Arterial Disease, sponsored by Kaiser Permanente.
NCT01588067 is a study of Peripheral Arterial Disease that has completed, run by Kaiser Permanente. The registered enrollment target is 271 participants, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01588067, a study of Peripheral Arterial Disease, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 271 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is designed to develop a clinical registry of Peripheral Arterial Disease (PAD) patients undergoing lower extremity revascularization to describe the population and assess comparative effectiveness of endovascular therapy versus surgery. In addition, this study will conduct a prospective cohort study of patients treated medically or undergoing lower extremity revascularization at the VA and Kaiser Colorado to compare changes in health status.
Primary Outcome
Health Status will be measured at baseline and six months following the procedure
Conditions Studied
Study Locations (2)
Colorado
- VA Eastern Colorado Health Care System - Denver
- Kaiser Permanente Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-09 |
What the finished NCT01588067 record still lists
NCT01588067 is an observational study that tracks outcomes without assigning an intervention. The registered 271 participants enrollment target is mid-sized for trials with a published cap, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01588067 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01588067 about?
NCT01588067 is a clinical study titled "Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease". This study is designed to develop a clinical registry of Peripheral Arterial Disease (PAD) patients undergoing lower extremity revascularization to describe the population and assess comparative effectiveness of endovascular therapy versus surgery. In addition, this study will conduct a prospective ...
What is the current status of trial NCT01588067?
This trial is currently completed. The enrollment target is 271 participants. The study started on 2011-05. Estimated completion is 2014-09.
What conditions does trial NCT01588067 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
Who is sponsoring clinical trial NCT01588067?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01588067 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01588067's enrollment target sits among peer trials
271 17th of 79 higher than 63 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03609216 · 271 participants · Phase 2
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia